Impaired hemostasis caused by beta-lactam antibiotics.
Beta-lactam antibiotics can directly impair hemostasis by two separate nonimmune mechanisms. First, the NMTT-substituted cephalosporin drugs may cause hypoprothrombinemia by interfering with the hepatic activation of clotting factors II, VII, IX, and X. Second, the antipseudomonal penicillins may cause the bleeding time to be prolonged by interfering with platelet aggregation to physiologic agonists. In surgical patients who are malnourished, have impaired gastrointestinal function, or have renal failure, the potential for these adverse effects is increased. Serious bleeding requires treatment with fresh frozen plasma when hypoprothrombinemia is caused by NMTT-containing cephalosporins, since the prothrombin time returns to baseline relatively slowly after therapy with vitamin K. Hemorrhage caused by beta-lactam-induced platelet dysfunction must be treated with platelet concentrates, since new platelets sufficient to correct the defect do not enter the circulation for several days after treatment with the offending drug is discontinued. The more desirable approach is to prevent hypoprothrombinemia by giving vitamin K prophylaxis and to avoid beta-lactams that impair platelet function in seriously ill patients at increased risk for bleeding.
Sattler
F R
FR
Los Angeles County University of Southern California Medical Center.
Weitekamp
M R
MR
Sayegh
A
A
Ballard
J O
JO
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001792:Blood Platelets / Q000187:drug effects*; D002511:Cephalosporins / Q000009:adverse effects; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced*; D010975:Platelet Aggregation Inhibitors; D012307:Risk Factors; D013329:Structure-Activity Relationship; D014812:Vitamin K / Q000378:metabolism
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010975:Platelet Aggregation Inhibitors; D014812:Vitamin K